Gelonghui April 23 丨 Shi Siyao Group (02005crashtagteamracingps2.HK) Announcementcrashtagteamracingps2, the group has obtained the relevant information from the State Food and Drug Administration of China regarding linezolid dry suspension (5ml)crashtagteamracingps2:100mg) drug production registration approval lettercrashtagteamracingps2, belonging to Class 4 of chemicals, is deemed to have passed the consistency evaluation.

Linezolid dry suspension is an oral suspension type. The Group is the first domestic company to be approved. It has previously obtained production approvals for linezolid's raw materials and injections. Linezolid dry suspension can be used in newborns, children and adult patients, mainly for the treatment of nosocomial pneumonia caused by sensitive strains of specific microorganisms, community-acquired pneumonia, skin and skin soft tissue infections, and vancomycin-resistant Enterococcus faecium infections